| Literature DB >> 33414070 |
Hannah C Zierden1, Aditya Josyula1, Rachel L Shapiro1, Henry T Hsueh1, Justin Hanes2, Laura M Ensign3.
Abstract
The efficacy of drugs administered by traditional routes is limited by numerous biological barriers that preclude reaching the intended site of action. Further, full body systemic exposure leads to dose-limiting, off-target side effects. Topical formulations may provide more efficacious drug and nucleic acid delivery for diseases and conditions affecting mucosal tissues, but the mucus protecting our epithelial surfaces is a formidable barrier. Here, we describe recent advances in mucus-penetrating approaches for drug and nucleic acid delivery to the ocular surface, the female reproductive tract, the gastrointestinal tract, and the airways.Entities:
Keywords: drug delivery; mucoadhesive; mucoinert; mucus; mucus penetrating; nanomedicine
Mesh:
Year: 2021 PMID: 33414070 PMCID: PMC8087626 DOI: 10.1016/j.molmed.2020.12.001
Source DB: PubMed Journal: Trends Mol Med ISSN: 1471-4914 Impact factor: 11.951